← Leaderboards
Timothy M. Miller
Washington University
$9,327,263
Attributed
$9,327,263
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2010–24$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,327,263 · 8
By mechanism
R01$5,654,874 · 2
R21$1,259,825 · 3
P50$987,501 · 1
U01$877,062 · 1
K08$548,001 · 1
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- Kathleen B Hall$7,200,714
- Scott L Crick$5,866,959
- Matthew Harms$9,320,977
- Tatyana Aleksandrovna Yakusheva$2,676,585
- Gerald W. Dorn$42,039,718
Others in their field
Top investigators on “Neurodegenerative Disorders”
- Adam L Boxer · Mayo Clinic Rochester$61,054,677
- Paul S. Aisen · Cognition Therapeutics, Inc.$56,063,985
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$55,774,157
- Reisa A. Sperling · Banner Health$50,784,577
- Jane S Paulsen · University Of Wisconsin-Madison$38,012,377
- John Q. Trojanowski · University Of Pennsylvania$37,152,274
Research focus
Neurodegenerative DisordersMotor NeuronsSpinal CordBrainAntisense OligonucleotidesAdultNovel TherapeuticsProteinsCessation Of LifeAmyotrophic Lateral SclerosisMessenger RnaAffectMouse ModelPharmaceutical PreparationsRespiratory MusclesMutationToxic EffectGrantClinicAnimal ModelNerve DegenerationDisease ProgressionKnockout MiceRespiratory Failure
Grant awards (30)
Directly Converted Neurons as a Novel Cellular Model for ALS and FTD$427,625
R21 · FY2024 · NS · contact PI
Using motor neuron specific miRNA to understand and develop novel therapeutics for motor neuron disease$448,083
R01 · FY2021 · NS · contact PI
Using motor neuron specific miRNA to understand and develop novel therapeutics for motor neuron disease$448,083
R01 · FY2020 · NS · contact PI
Using motor neuron specific miRNA to understand and develop novel therapeutics for motor neuron disease$448,083
R01 · FY2019 · NS · contact PI
Understanding SOD1 Kinetics in Amyotrophic Lateral Sclerosis$598,378
R01 · FY2018 · NS · contact PI
Using motor neuron specific miRNA to understand and develop novel therapeutics for motor neuron disease$450,601
R01 · FY2018 · NS · contact PI
Understanding SOD1 Kinetics in Amyotrophic Lateral Sclerosis$595,862
R01 · FY2017 · NS · contact PI
Using motor neuron specific miRNA to understand and develop novel therapeutics for motor neuron disease$492,369
R01 · FY2017 · NS · contact PI
Understanding SOD1 Kinetics in Amyotrophic Lateral Sclerosis$524,052
R01 · FY2016 · NS · contact PI
DEVELOPING A MICRORNA-TARGETED THERAPY FOR ALS$332,500
R01 · FY2016 · NS · contact PI
Development of an antisense oligonucleotide therapy for SOD1 Familial ALS$443,780
U01 · FY2015 · NS · contact PI
DEVELOPING A MICRORNA-TARGETED THERAPY FOR ALS$332,500
R01 · FY2015 · NS · contact PI
Development of an antisense oligonucleotide therapy for SOD1 Familial ALS$144,807
U01 · FY2015 · NS · contact PI
DEVELOPING A MICRORNA-TARGETED THERAPY FOR ALS$329,176
R01 · FY2014 · NS · contact PI
Development of an antisense oligonucleotide therapy for SOD1 Familial ALS$288,475
U01 · FY2014 · NS · contact PI
CHANGING TAU PROTEIN LEVELS AND TAU PROTEIN ISOFORMS IN MOUSE MODELS OF DEMENTIA$202,257
P50 · FY2014 · AG · contact PI
DOES A SHIFT FROM 4R TO 3R TAU PROJECT AGAINST AMYLOID BETA-INDUCED COGNITIVE DEF$190,000
R21 · FY2014 · AG · contact PI
DEVELOPING A MICRORNA-TARGETED THERAPY FOR ALS$1,824
R01 · FY2014 · NS · contact PI
DEVELOPING A MICRORNA-TARGETED THERAPY FOR ALS$320,863
R01 · FY2013 · NS · contact PI
Effect of SHIFT FROM 4R TO 3R TAU on AMYLOID BETA-INDUCED COGNITIVE DEFICITS$228,000
R21 · FY2013 · AG · contact PI
CHANGING TAU PROTEIN LEVELS AND TAU PROTEIN ISOFORMS IN MOUSE MODELS OF DEMENTIA$189,241
P50 · FY2013 · AG · contact PI
DEVELOPING A MICRORNA-TARGETED THERAPY FOR ALS$332,500
R01 · FY2012 · NS · contact PI
CHANGING TAU PROTEIN LEVELS AND TAU PROTEIN ISOFORMS IN MOUSE MODELS OF DEMENTIA$196,118
P50 · FY2012 · AG · contact PI
Changing tau Protein Levels and tau Protein Isoforms in Mouse Models of Dementia$182,667
K08 · FY2012 · NS · contact PI
CHANGING TAU PROTEIN LEVELS AND TAU PROTEIN ISOFORMS IN MOUSE MODELS OF DEMENTIA$197,390
P50 · FY2011 · AG · contact PI
Identifying Liver Proteins that Decrease Mutant SOD1 Misfolding and Decrease SOD1$186,200
R21 · FY2011 · NS · contact PI
Changing tau Protein Levels and tau Protein Isoforms in Mouse Models of Dementia$182,667
K08 · FY2011 · NS · contact PI
Identifying Liver Proteins that Decrease Mutant SOD1 Misfolding and Decrease SOD1$228,000
R21 · FY2010 · NS · contact PI
CHANGING TAU PROTEIN LEVELS AND TAU PROTEIN ISOFORMS IN MOUSE MODELS OF DEMENTIA$202,495
P50 · FY2010 · AG · contact PI
Changing tau Protein Levels and tau Protein Isoforms in Mouse Models of Dementia$182,667
K08 · FY2010 · NS · contact PI